SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/21 Fuse Medical, Inc. 10-K 12/31/20 72:7.1M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 751K 2: EX-10.21 Material Contract HTML 28K 3: EX-21.1 Subsidiaries List HTML 20K 4: EX-23.1 Consent of Expert or Counsel HTML 21K 5: EX-23.2 Consent of Expert or Counsel HTML 21K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 29K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 15: R1 Document and Entity Information HTML 82K 16: R2 Consolidated Balance Sheets HTML 106K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K 18: R4 Consolidated Statements of Operations HTML 91K 19: R5 Consolidated Statement of Changes in Stockholders' HTML 46K Equity 20: R6 Consolidated Statements of Cash Flows HTML 99K 21: R7 Nature of Operations HTML 34K 22: R8 Significant Accounting Policies HTML 85K 23: R9 Property and Equipment HTML 45K 24: R10 Goodwill and Intangible Assets HTML 78K 25: R11 Senior Secured Revolving Credit Facility HTML 30K 26: R12 Notes Payable - Related Parties HTML 24K 27: R13 Paycheck Protection Program Loan HTML 24K 28: R14 Economic Injury Disaster Loan HTML 24K 29: R15 Commitments and Contingencies HTML 39K 30: R16 Stockholders' Equity HTML 132K 31: R17 Income Taxes HTML 148K 32: R18 Concentrations HTML 49K 33: R19 Related Party Transactions HTML 46K 34: R20 Subsequent Events HTML 25K 35: R21 Significant Accounting Policies (Policies) HTML 136K 36: R22 Significant Accounting Policies (Tables) HTML 49K 37: R23 Property and Equipment (Tables) HTML 44K 38: R24 Goodwill and Intangible Assets (Tables) HTML 78K 39: R25 Commitments and Contingencies (Tables) HTML 36K 40: R26 Stockholders' Equity (Tables) HTML 131K 41: R27 Income Taxes (Tables) HTML 148K 42: R28 Concentrations (Tables) HTML 53K 43: R29 Nature of Operations (Details Narrative) HTML 75K 44: R30 Significant Accounting Policies (Details HTML 102K Narrative) 45: R31 Significant Accounting Policies - Estimated Useful HTML 31K Lives of Assets (Details) 46: R32 Significant Accounting Policies - Schedule of HTML 31K Revenue Differentiation (Details) 47: R33 Property and Equipment - Summary of Property and HTML 33K Equipment (Details) 48: R34 Property and Equipment (Details Narrative) HTML 25K 49: R35 Goodwill and Intangible Assets - Schedule of HTML 47K Goodwill and Other Intangible Assets (Details) 50: R36 Goodwill and Intangible Assets - (Details HTML 26K Narrative) 51: R37 Goodwill and Intangible Assets - Schedule of HTML 37K Future Amortization Expense Related to Finite-Live Intangible Assets (Details) 52: R38 Senior Secured Revolving Credit Facility (Details HTML 137K Narrative) 53: R39 Notes Payable - Related Parties (Details HTML 59K Narrative) 54: R40 Paycheck Protection Program Loan (Details HTML 39K Narrative) 55: R41 Economic Injury Disaster Loan (Details Narrative) HTML 51K 56: R42 Commitments and Contingencies (Details Narrative) HTML 37K 57: R43 Commitments and Contingencies - Summary of HTML 31K Operating Leases (Details) 58: R44 Stockholders' Equity - Summary of Compensation HTML 38K Expense for Stock Options Granted to Board Members, Employees And Marketing Representatives (Details) 59: R45 Stockholders' Equity (Details Narrative) HTML 33K 60: R46 Stockholders' Equity - Summary of Stock Option HTML 52K Activity (Details) 61: R47 Stockholders' Equity - Summary of Restricted Stock HTML 42K Awards Activity (Details) 62: R48 Income Taxes - Components of Income Tax Expense HTML 42K (Benefit) (Details) 63: R49 Income Taxes - Significant Components of Deferred HTML 53K Income Tax Assets and Liabilities (Details) 64: R50 Income Taxes (Details Narrative) HTML 36K 65: R51 Income Taxes - Reconciliation of Income Tax HTML 35K Computed at U.S. Statutory Rate to Effective Income Tax Rate (Details) 66: R52 Concentrations - Significant Customers with HTML 29K Individual Percentage of Total Revenues Equaling Ten Percent (10%) or Greater (Details) 67: R53 Concentrations - Significant Customers with HTML 29K Concentration of Accounts Receivable Representing Ten Percent (10%) or Greater of Accounts Receivable (Parenthetical) (Details) 68: R54 Concentrations - Significant Customers with HTML 31K Concentration of Accounts Receivable Representing Ten Percent (10%) or Greater of Accounts Receivable (Details) 69: R55 Related Party Transactions (Details Narrative) HTML 87K 71: XML IDEA XML File -- Filing Summary XML 127K 70: EXCEL IDEA Workbook of Financial Reports XLSX 87K 9: EX-101.INS XBRL Instance -- fzmd-20201231 XML 1.65M 11: EX-101.CAL XBRL Calculations -- fzmd-20201231_cal XML 160K 12: EX-101.DEF XBRL Definitions -- fzmd-20201231_def XML 543K 13: EX-101.LAB XBRL Labels -- fzmd-20201231_lab XML 1.26M 14: EX-101.PRE XBRL Presentations -- fzmd-20201231_pre XML 917K 10: EX-101.SCH XBRL Schema -- fzmd-20201231 XSD 181K 72: ZIP XBRL Zipped Folder -- 0001564590-21-016781-xbrl Zip 141K
Exhibit 21.1
Fuse Medical, Inc.
(A Delaware Corporation)
List of Significant Subsidiaries
(As of December 31, 2019)
CPM Medical Consultants, LLC
Palm Springs Partners, LLC D/B/A Maxim Surgical
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 3/31/21 | 10-Q | ||
Filed on: | 3/30/21 | |||
For Period end: | 12/31/20 | |||
12/31/19 | 10-K | |||
List all Filings |